LAMISIL AT ANTIFUNGAL- terbinafine gel 
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC

----------

Drug Facts

Active ingredient

Terbinafine1%

Purpose

Antifungal

Uses

cures most athlete’s foot (tinea pedis) between the toes.
 
Effectiveness on the bottom or sides of foot is unknown.
cures most jock itch (tinea cruris) and ringworm (tinea corporis)
relieves itching, burning, cracking and scaling which accompany these conditions

Warnings

For external use only

Do not use

on nails or scalp
in or near the mouth or eyes
for vaginal yeast infections

Ask Doctor before use if you have

Ask a doctor or pharmacist

When using this product

do not get into eyes. If eye contact occurs, rinse thoroughly with water.

Stop use and ask a doctor

do not get into eyes. If eye contact occurs, rinse thoroughly with water.

Keep Out of Reach of Children

If swallowed, get medical help or contact a poison control center right away.

Directions

adults and children 12 years and over
use the tip of the cap to break the seal and open the tube
wash the affected skin with soap and water and dry completely before applying
for athlete’s footbetween the toes: apply once a day at bedtime for 1 week or as directed by a doctor. Wear well-fitting, ventilated shoes. Change shoes and socks at least once daily 
image 1

1 week between the toes

 
for jock itch and ringworm: apply once a day (morning or night) for 1 week or as directed by a doctor.
wash hands after each use
children under 12 years: ask a doctor

Other information

do not use if seal on tube is broken or is not visible
store at or below 30°C (86°F)

Inactive ingredients

benzyl alcohol, butylated hydroxytoluene, carbomer 974 P, ethanol, isopropyl myristate, polysorbate 20, purified water, sodium hydroxide, sorbitan monolaurate

Questions

Questions? call 1-800-452-0051

 

Distributed by:

Novartis Consumer Health, Inc.

Parsippany, NJ 07054-0622

Principal Display Panel

Lamisil AT Antifungal Gel

[Enter image caption here]

LAMISIL AT  ANTIFUNGAL
terbinafine gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0067-6239
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TERBINAFINE (UNII: G7RIW8S0XP) (TERBINAFINE - UNII:G7RIW8S0XP) TERBINAFINE10 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
ALCOHOL (UNII: 3K9958V90M)  
BENZYL ALCOHOL (UNII: LKG8494WBH)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)  
POLYSORBATE 20 (UNII: 7T1F30V5YH)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
SORBITAN MONOLAURATE (UNII: 6W9PS8B71J)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0067-6239-421 in 1 CONTAINER01/01/201012/31/2017
112 g in 1 TUBE; Type 0: Not a Combination Product
2NDC:0067-6239-211 in 1 CONTAINER01/01/201012/31/2017
26 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02195801/01/201012/31/2017
Labeler - GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (079944263)

Revised: 1/2018
 
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC